AU2003211267A1 - Solid preparations with improved absorbability of hardly water-soluble drug - Google Patents

Solid preparations with improved absorbability of hardly water-soluble drug

Info

Publication number
AU2003211267A1
AU2003211267A1 AU2003211267A AU2003211267A AU2003211267A1 AU 2003211267 A1 AU2003211267 A1 AU 2003211267A1 AU 2003211267 A AU2003211267 A AU 2003211267A AU 2003211267 A AU2003211267 A AU 2003211267A AU 2003211267 A1 AU2003211267 A1 AU 2003211267A1
Authority
AU
Australia
Prior art keywords
soluble drug
solid preparations
hardly water
improved absorbability
absorbability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003211267A
Inventor
Takashi Hayashi
Asako Takakura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2003211267A1 publication Critical patent/AU2003211267A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AU2003211267A 2002-02-27 2003-02-24 Solid preparations with improved absorbability of hardly water-soluble drug Abandoned AU2003211267A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002052017 2002-02-27
JP2002-52017 2002-02-27
PCT/JP2003/001965 WO2003072085A1 (en) 2002-02-27 2003-02-24 Solid preparations with improved absorbability of hardly water-soluble drug

Publications (1)

Publication Number Publication Date
AU2003211267A1 true AU2003211267A1 (en) 2003-09-09

Family

ID=27764326

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003211267A Abandoned AU2003211267A1 (en) 2002-02-27 2003-02-24 Solid preparations with improved absorbability of hardly water-soluble drug

Country Status (3)

Country Link
JP (1) JP4632288B2 (en)
AU (1) AU2003211267A1 (en)
WO (1) WO2003072085A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012150675A1 (en) * 2011-05-02 2012-11-08 ライオン株式会社 Panaxadiol-containing composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914618A (en) * 1972-06-02 1974-02-08
JPS649932A (en) * 1987-07-01 1989-01-13 Toyo Capsel Kk Soft capsule preparation using newly combined component as the base
JPH0662411B2 (en) * 1991-12-27 1994-08-17 わかもと製薬株式会社 Process for producing pharmaceutical composition containing 5- (3-n-butyloxalylaminophenyl) tetrazole
KR100355130B1 (en) * 1992-09-18 2003-01-30 야마노우치세이야쿠 가부시키가이샤 Hydrogel Sustained Release Tablet
BE1006990A5 (en) * 1993-04-22 1995-02-07 Univ Gent METHOD AND COMPOSITION TO MAKE AN ACTIVE INGREDIENT IN A solid dosage form.
JPH07291854A (en) * 1994-04-26 1995-11-07 Tanabe Seiyaku Co Ltd Medicinal preparation improved in solubility
JPH08291063A (en) * 1995-04-21 1996-11-05 Maruho Kk Readily absorbable pharmaceutical preparation and its production
SK282995B6 (en) * 1996-01-23 2003-01-09 Shionogi And Co., Ltd. Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same
AU7675198A (en) * 1997-06-30 1999-01-19 Chugai Seiyaku Kabushiki Kaisha Sucralfate-containing composition and process for the preparation thereof
BR0014351A (en) * 1999-09-27 2002-06-11 American Cyanamid Co Formulation and process of vasopressin antagonist
AU2001248765A1 (en) * 2000-04-21 2001-11-12 Shionogi And Co., Ltd. Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders
KR20010107754A (en) * 2000-05-26 2001-12-07 민경윤 Process for preparing rapidly disintegrating tablet for oral administration
JP4644397B2 (en) * 2001-09-05 2011-03-02 信越化学工業株式会社 Method for producing pharmaceutical solid preparation containing poorly soluble drug

Also Published As

Publication number Publication date
JPWO2003072085A1 (en) 2005-06-16
JP4632288B2 (en) 2011-02-16
WO2003072085A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
AU2003273000A1 (en) Stable solid preparations
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2319100A (en) Amide derivatives and drug compositions
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU2003901813A0 (en) Pharmaceutical derivatives
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2002950853A0 (en) Aminopyrimidine compound and pharmaceutical use thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002346457A1 (en) Pharmaceutical formulations comprising indolinone derivatives
AU3971500A (en) Indazole derivatives, preparation and therapeutic application thereof
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2003211267A1 (en) Solid preparations with improved absorbability of hardly water-soluble drug
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application
AU1172101A (en) Phytoestrogenic pharmaceutical preparations
AU2003260566A1 (en) Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine
AU4504201A (en) Drug preparations
AU2002238688A1 (en) Aryl carbamate derivatives, preparation and use thereof
AU2003215543A1 (en) Water- soluble derivatives of lipophilic drugs
AU2001276556A1 (en) Novel pharmaceutical use of quinnoline derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase